Metformin Zentiva 500 mg Filmdragerad tablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

metformin zentiva 500 mg filmdragerad tablett

zentiva k.s. - metforminhydroklorid - filmdragerad tablett - 500 mg - metforminhydroklorid 500 mg aktiv substans

Metformin Meda 500 mg Tablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

metformin meda 500 mg tablett

meda ab - metforminhydroklorid - tablett - 500 mg - sorbitol hjälpämne; metforminhydroklorid 500 mg aktiv substans - metformin

Metformin PharmConsul 500 mg Filmdragerad tablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

metformin pharmconsul 500 mg filmdragerad tablett

pharmconsul s.r.o. - metforminhydroklorid - filmdragerad tablett - 500 mg - metforminhydroklorid 500 mg aktiv substans

Metformin EQL 500 mg Filmdragerad tablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

metformin eql 500 mg filmdragerad tablett

eql pharma ab - metforminhydroklorid - filmdragerad tablett - 500 mg - metforminhydroklorid 500 mg aktiv substans; propylenglykol hjälpämne

Vildagliptin / Metformin hydrochloride Accord Europeiska unionen - svenska - EMA (European Medicines Agency)

vildagliptin / metformin hydrochloride accord

accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabetes mellitus, typ 2 - läkemedel som används vid diabetes - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 och 5. 1 för tillgänglig data på olika kombinationer).

Sitagliptin / Metformin hydrochloride Accord Europeiska unionen - svenska - EMA (European Medicines Agency)

sitagliptin / metformin hydrochloride accord

accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - diabetes mellitus, typ 2 - läkemedel som används vid diabetes - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. it is indicated in combination with a sulphonylurea (i. - , trippel kombinationsterapi) som ett komplement till kost och motion hos patienter bristfälligt kontrollerad på deras maximal tolererad dos av metformin och en sulphonylurea. it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. it is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Metformin EQL Pharma 500 mg Filmdragerad tablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

metformin eql pharma 500 mg filmdragerad tablett

eql pharma ab - metforminhydroklorid - filmdragerad tablett - 500 mg - metforminhydroklorid 500 mg aktiv substans - metformin

Sitagliptin / Metformin hydrochloride Mylan Europeiska unionen - svenska - EMA (European Medicines Agency)

sitagliptin / metformin hydrochloride mylan

mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - diabetes mellitus, typ 2 - läkemedel som används vid diabetes - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. - , trippel kombinationsterapi) som ett komplement till kost och motion hos patienter bristfälligt kontrollerad på deras maximal tolererad dos av metformin och en sulphonylurea. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Metformin Sandoz 850 mg Filmdragerad tablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

metformin sandoz 850 mg filmdragerad tablett

sandoz a/s - metforminhydroklorid - filmdragerad tablett - 850 mg - metforminhydroklorid 850 mg aktiv substans - metformin

Metformin Bluefish 1000 mg Filmdragerad tablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

metformin bluefish 1000 mg filmdragerad tablett

bluefish pharmaceuticals ab - metforminhydroklorid - filmdragerad tablett - 1000 mg - metforminhydroklorid 1000 mg aktiv substans - metformin